These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25117462)

  • 41. Premature age-related comorbidities among HIV-infected persons compared with the general population.
    Guaraldi G; Orlando G; Zona S; Menozzi M; Carli F; Garlassi E; Berti A; Rossi E; Roverato A; Palella F
    Clin Infect Dis; 2011 Dec; 53(11):1120-6. PubMed ID: 21998278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determinants of immunological and virological responses to antiretroviral therapy amongst HIV-infected adults in central Argentina: negative influence of hepatitis C infection.
    Farías AA; Kremer LE; Allende L; Díaz Mdel P; Pisano MB; Contigiani MS; Ré VE
    Trans R Soc Trop Med Hyg; 2013 Jul; 107(7):432-7. PubMed ID: 23761392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
    Hansen AB; Lindegaard B; Obel N; Andersen O; Nielsen H; Gerstoft J
    HIV Med; 2006 Jan; 7(1):38-45. PubMed ID: 16313291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence and determinants of selected cardio-metabolic risk factors among people living with HIV/AIDS and receiving care in the South West Regional Hospitals of Cameroon: a cross-sectional study.
    Ngu RC; Choukem SP; Dimala CA; Ngu JN; Monekosso GL
    BMC Res Notes; 2018 May; 11(1):305. PubMed ID: 29769110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multicenter cohort study of diabetes mellitus and impaired fasting glucose in HIV-infected patients in China.
    Zhang C; Chow FC; Han Y; Xie J; Qiu Z; Guo F; Li Y; Wang H; Li T
    J Acquir Immune Defic Syndr; 2015 Mar; 68(3):298-303. PubMed ID: 25469524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glycaemic profile changes by highly active antiretroviral therapy in human immunodeficiency virus-infected patients.
    Duro M; Rebelo I; Barreira S; Sarmento-Castro R; Medeiros R; Almeida C
    Int J STD AIDS; 2015 Oct; 26(11):796-802. PubMed ID: 25281540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV/hepatitis C virus-coinfected patients.
    Hull MW; Rollet K; Moodie EE; Walmsley S; Cox J; Potter M; Cooper C; Pick N; Saeed S; Klein MB;
    AIDS; 2012 Sep; 26(14):1789-94. PubMed ID: 22739388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence of diabetes mellitus in a population-based cohort of HIV-infected and non-HIV-infected persons: the impact of clinical and therapeutic factors over time.
    Tripathi A; Liese AD; Jerrell JM; Zhang J; Rizvi AA; Albrecht H; Duffus WA
    Diabet Med; 2014 Oct; 31(10):1185-93. PubMed ID: 24673640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy.
    Estrada V; Martínez-Larrad MT; González-Sánchez JL; de Villar NG; Zabena C; Fernández C; Serrano-Ríos M
    Metabolism; 2006 Jul; 55(7):940-5. PubMed ID: 16784968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
    Petoumenos K; Worm SW; Fontas E; Weber R; De Wit S; Bruyand M; Reiss P; El-Sadr W; Monforte AD; Friis-Møller N; Lundgren JD; Law MG;
    J Int AIDS Soc; 2012 Oct; 15(2):17426. PubMed ID: 23078769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.
    Braitstein P; Nyandiko W; Vreeman R; Wools-Kaloustian K; Sang E; Musick B; Sidle J; Yiannoutsos C; Ayaya S; Carter EJ
    Pediatr Infect Dis J; 2009 Jul; 28(7):626-32. PubMed ID: 19451858
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy.
    Wongprasit P; Manosuthi W; Kiertiburanakul S; Sungkanuparph S
    AIDS Patient Care STDS; 2010 Apr; 24(4):205-9. PubMed ID: 20377434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of lipodystrophy in HIV-infected children in Tanzania on highly active antiretroviral therapy.
    Kinabo GD; Sprengers M; Msuya LJ; Shayo AM; van Asten H; Dolmans WM; van der Ven AJ; Warris A
    Pediatr Infect Dis J; 2013 Jan; 32(1):39-44. PubMed ID: 23038217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
    Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
    J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of demographic characteristics and upper gastrointestinal endoscopy findings in HIV-positive, antiretroviral-treated patients with and without Helicobacter pylori coinfection.
    Nkuize M; De Wit S; Muls V; Ntounda R; Gomez-Galdon M; Buset M
    Helicobacter; 2012 Apr; 17(2):153-9. PubMed ID: 22404447
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolic syndrome in French HIV-infected patients: prevalence and predictive factors after 3 years of antiretroviral therapy.
    Biron A; Bobin-Dubigeon C; Volteau C; Piroth L; Perré P; Leport C; Prazuck T; Jovelin T; Billard M; Sébille V; Bard JM; Raffi F; Biron C
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1672-8. PubMed ID: 22731114
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prevalence and related factors on diabetes among HIV/AIDS receiving antiretroviral therapy in Dehong Dai and Jingpo Autonomous Prefecture].
    Ye RH; Li J; Yao ST; Wang JB; Cao DD; Zhang YD; Shi Y; Li PY; Xu YW; Wei H; Xiao GF; Sun JT; Duan X; Wang YK; Yang J; He N; Ding YY; Duan S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jun; 40(6):654-659. PubMed ID: 31238614
    [No Abstract]   [Full Text] [Related]  

  • 58. African Mitochondrial DNA Haplogroup L2 Is Associated With Slower Decline of β-cell Function and Lower Incidence of Diabetes Mellitus in Non-Hispanic, Black Women Living With Human Immunodeficiency Virus.
    Sun J; Brown TT; Tong W; Samuels D; Tien P; Aissani B; Aouizerat B; Villacres M; Kuniholm MH; Gustafson D; Michel K; Cohen M; Schneider M; Adimora AA; Ali MK; Bolivar H; Hulgan T
    Clin Infect Dis; 2020 Nov; 71(8):e218-e225. PubMed ID: 31927570
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between the use of protease inhibitors in highly active antiretroviral therapy and incidence of diabetes mellitus and/or metabolic syndrome in HIV-infected patients: A systematic review and meta-analysis.
    Echecopar-Sabogal J; D'Angelo-Piaggio L; Chanamé-Baca DM; Ugarte-Gil C
    Int J STD AIDS; 2018 Apr; 29(5):443-452. PubMed ID: 28956700
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and incidence of pre-diabetes and diabetes mellitus among people living with HIV in Ghana: Evidence from the EVERLAST Study.
    Sarfo FS; Norman B; Nichols M; Appiah L; Osei Assibey S; Tagge R; Ovbiagele B
    HIV Med; 2021 Apr; 22(4):231-243. PubMed ID: 33174302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.